Last reviewed · How we verify
NCT04996472
A Framework For Linking Sequential Pattern Rules in DLD: Perception in Adults
NA trial testing Sensitivity to phonological rules: Adults in Developmental Language Disorder in 933 participants. Completed in 17 May 2025.
17 May 2025
Quick facts
| Lead sponsor | Father Flanagan's Boys' Home |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | basic science |
| Enrollment | 933 |
| Start date | 3 August 2020 |
| Primary completion | 17 May 2025 |
| Estimated completion | 17 May 2025 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Sensitivity to phonological rules: Adults
- Sensitivity to semantic category cues: Adults
Conditions studied
- Developmental Language Disorder — all drugs for Developmental Language Disorder →
- Speech Sound Disorder — all drugs for Speech Sound Disorder →
- Specific Language Impairment — all drugs for Specific Language Impairment →
Sponsor
Father Flanagan's Boys' Home
Who can join
Adults 18 to 30, any sex, with Developmental Language Disorder or Speech Sound Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This broad aim of this clinical study is to assess the hypothesis that morphological and phonological deficits are linked by a broader deficit in sequential pattern learning. This hypothesis applies to learning in general, but is especially critical as an avenue for developing earlier assessments and more powerful interventions for children with developmental language disorder (DLD; AKA specific language impairment). Other populations, such as at-risk toddlers, may also benefit from this new approach.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04996472
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Developmental Language Disorder
Currently open trials in the same condition.
- NCT07519629 — Training Caregivers to Teach Vocabulary to Children With Language Impairment · NA · recruiting
- NCT06660108 — MOLECULAR BASIS OF LANGUAGE DEVELOPMENT AND ASSOCIATED DISORDERS · NA · recruiting
- NCT06866223 — Emergent Bilinguals: Child Language Proficiency and Language of Treatment · NA · recruiting
- NCT06995014 — Retrieval-based Word Learning in Developmental Language Disorder: Adaptive Retrieval Schedule · NA · recruiting
- NCT06340893 — Exercise Training in Children With Communication Impairments · NA · recruiting
Other Father Flanagan's Boys' Home trials
Trials by the same sponsor.
- NCT06794476 — Milieu Teaching-AV (MT-AV Pilot) · NA · withdrawn
- NCT06852664 — Improving Activity in Individuals With Cerebral Palsy · NA · recruiting
- NCT05815537 — Development of Functional Spatial Hearing in Reverberation · EARLY_PHASE1 · completed
- NCT04558541 — A Developmental Framework For Linking Phonological And Morpho-syntactic Sequential Pattern Rules In DLD: Production · NA · recruiting
- NCT05486637 — Vocal Emotion Communication With Cochlear Implants · EARLY_PHASE1 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04996472 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Father Flanagan's Boys' Home
- Last refreshed: 27 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04996472.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing